Liraglutide
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Novo Nordisk · Phase 3 · Completed · Enrollment 153
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Metformin XR plus liraglutide | n/r | n/r | n/r | n/r |
| Metformin XR plus placebo | n/r | n/r | n/r | n/r |
Not shown
- Metformin XR plus liraglutide: endpoint not reported
- Metformin XR plus placebo: endpoint not reported